No Data
No Data
Express News | Internationals look forward to more opportunities for cooperation in lunar exploration
A new milestone (002219): Performance is in line with expectations, and the profitability of the medical service business continues to improve
Incident: The company released its 2023 annual report. In 2023, it achieved operating income of 3,590 billion yuan (+13.59%) and net profit attributable to shareholders of listed companies of 30.78 million yuan (-80.29%), which was not deducted
Caring Life once again releases a “blood supplement” signal to partner with Xinmileage Health to seek managed medical treatment
There are quite a few institutions to explore and open up health care and insurance, but the investment is also huge, so it's not easy.
New Mileage (002219.SZ): Net profit of 244.496 million yuan in the first quarter increased 12.19% year-on-year
On April 25, Ge Longhui (002219.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 863 million yuan, up 9.85% year on year; net profit attributable to shareholders of listed companies was 24.404.96 million yuan, up 12.19% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 25.164,900 yuan, up 22.47% year on year; basic earnings per share were 0.0072 yuan.
New Milestone (002219): Performance meets expectations and accelerates construction of new hospitals
Event: On April 17, 2024, the company released its 2023 annual report. In 2023, the company achieved operating income of 3,590 billion yuan, an increase of 13.59% over the previous year, and achieved net profit of 31 million yuan to mother
SDIC Securities released a research report on April 18 stating that the target price for the new mileage (002219.SZ) purchase rating will be 3.24 yuan. The main reasons for the rating include: 1) performance is in line with expectations, excluding the inf
SDIC Securities released a research report on April 18 stating that the target price for the new mileage (002219.SZ) purchase rating will be 3.24 yuan. The main reasons for the rating include: 1) performance is in line with expectations, excluding the influence of equity incentives to achieve relatively rapid year-on-year growth; 2) speeding up the construction of new hospitals and enhancing regional competitiveness. (Mainichi Keizai Shimbun)
No Data